+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biologic Therapeutics Market 2024-2028

  • PDF Icon

    Report

  • 184 Pages
  • August 2024
  • Region: Global
  • TechNavio
  • ID: 5786819
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The biologic therapeutics market is forecasted to grow by USD 398.3 billion during 2023-2028, accelerating at a CAGR of 13.64% during the forecast period. The report on the biologic therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by introduction of biosimilars, increasing incidence of chronic diseases and immunological disorders, and patent expiry of major biologics.

The biologic therapeutics market is segmented as below:

By Application

  • Cancer
  • Infectious diseases
  • Autoimmune diseases
  • Others

By Product

  • Antibody therapeutics
  • Vaccines
  • Cell therapy
  • Gene therapy
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the strong research and development pipeline as one of the prime reasons driving the biologic therapeutics market growth during the next few years. Also, targeted therapeutic mechanism of biologics and increasing investment in developing biologics will lead to sizable demand in the market.

The report on the biologic therapeutics market covers the following areas:

  • Biologic therapeutics market sizing
  • Biologic therapeutics market forecast
  • Biologic therapeutics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biologic therapeutics market vendors that include AbbVie Inc., Amgen Inc., Apogenix AG, AstraZeneca Plc, Aurobindo Pharma Ltd., Baxter International Inc., Biocon Ltd., BioMarin Pharmaceutical Inc., Celltrion Healthcare Co. Ltd., Eli Lilly and Co., GangaGen Biotechnologies Pvt Ltd., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Merck and Co. Inc., Novartis AG, Pfizer Inc., Precision Biologics Inc., Samsung Electronics Co. Ltd., Sanofi SA, and Tubulis GmbH. Also, the biologic therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Market Segmentation by Product
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ billion)
Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Biologic Therapeutics Market 2018 - 2022
Historic Market Size - Data Table on Global Biologic Therapeutics Market 2018 - 2022 ($ billion)
4.2 Application segment analysis 2018 - 2022
Historic Market Size - Application Segment 2018 - 2022 ($ billion)
4.3 Product segment analysis 2018 - 2022
Historic Market Size - Product Segment 2018 - 2022 ($ billion)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Application
6.1 Market segments
Chart on Application - Market share 2023-2028 (%)
Data Table on Application - Market share 2023-2028 (%)
6.2 Comparison by Application
Chart on Comparison by Application
Data Table on Comparison by Application
6.3 Cancer - Market size and forecast 2023-2028
Chart on Cancer - Market size and forecast 2023-2028 ($ billion)
Data Table on Cancer - Market size and forecast 2023-2028 ($ billion)
Chart on Cancer - Year-over-year growth 2023-2028 (%)
Data Table on Cancer - Year-over-year growth 2023-2028 (%)
6.4 Infectious diseases - Market size and forecast 2023-2028
Chart on Infectious diseases - Market size and forecast 2023-2028 ($ billion)
Data Table on Infectious diseases - Market size and forecast 2023-2028 ($ billion)
Chart on Infectious diseases - Year-over-year growth 2023-2028 (%)
Data Table on Infectious diseases - Year-over-year growth 2023-2028 (%)
6.5 Autoimmune diseases - Market size and forecast 2023-2028
Chart on Autoimmune diseases - Market size and forecast 2023-2028 ($ billion)
Data Table on Autoimmune diseases - Market size and forecast 2023-2028 ($ billion)
Chart on Autoimmune diseases - Year-over-year growth 2023-2028 (%)
Data Table on Autoimmune diseases - Year-over-year growth 2023-2028 (%)
6.6 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ billion)
Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
6.7 Market opportunity by Application
Market opportunity by Application ($ billion)
Data Table on Market opportunity by Application ($ billion)
7 Market Segmentation by Product
7.1 Market segments
Chart on Product - Market share 2023-2028 (%)
Data Table on Product - Market share 2023-2028 (%)
7.2 Comparison by Product
Chart on Comparison by Product
Data Table on Comparison by Product
7.3 Antibody therapeutics - Market size and forecast 2023-2028
Chart on Antibody therapeutics - Market size and forecast 2023-2028 ($ billion)
Data Table on Antibody therapeutics - Market size and forecast 2023-2028 ($ billion)
Chart on Antibody therapeutics - Year-over-year growth 2023-2028 (%)
Data Table on Antibody therapeutics - Year-over-year growth 2023-2028 (%)
7.4 Vaccines - Market size and forecast 2023-2028
Chart on Vaccines - Market size and forecast 2023-2028 ($ billion)
Data Table on Vaccines - Market size and forecast 2023-2028 ($ billion)
Chart on Vaccines - Year-over-year growth 2023-2028 (%)
Data Table on Vaccines - Year-over-year growth 2023-2028 (%)
7.5 Cell therapy - Market size and forecast 2023-2028
Chart on Cell therapy - Market size and forecast 2023-2028 ($ billion)
Data Table on Cell therapy - Market size and forecast 2023-2028 ($ billion)
Chart on Cell therapy - Year-over-year growth 2023-2028 (%)
Data Table on Cell therapy - Year-over-year growth 2023-2028 (%)
7.6 Gene therapy - Market size and forecast 2023-2028
Chart on Gene therapy - Market size and forecast 2023-2028 ($ billion)
Data Table on Gene therapy - Market size and forecast 2023-2028 ($ billion)
Chart on Gene therapy - Year-over-year growth 2023-2028 (%)
Data Table on Gene therapy - Year-over-year growth 2023-2028 (%)
7.7 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ billion)
Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
7.8 Market opportunity by Product
Market opportunity by Product ($ billion)
Data Table on Market opportunity by Product ($ billion)
8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ billion)
Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ billion)
Data Table on US - Market size and forecast 2023-2028 ($ billion)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ billion)
Data Table on China - Market size and forecast 2023-2028 ($ billion)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 France - Market size and forecast 2023-2028
Chart on France - Market size and forecast 2023-2028 ($ billion)
Data Table on France - Market size and forecast 2023-2028 ($ billion)
Chart on France - Year-over-year growth 2023-2028 (%)
Data Table on France - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Chart on Japan - Year-over-year growth 2023-2028 (%)
Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ billion)
Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints
11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business
12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
12.4 Amgen Inc.
Amgen Inc. - Overview
Amgen Inc. - Product / Service
Amgen Inc. - Key news
Amgen Inc. - Key offerings
12.5 AstraZeneca Plc
AstraZeneca Plc - Overview
AstraZeneca Plc - Product / Service
AstraZeneca Plc - Key news
AstraZeneca Plc - Key offerings
12.6 Aurobindo Pharma Ltd.
Aurobindo Pharma Ltd. - Overview
Aurobindo Pharma Ltd. - Product / Service
Aurobindo Pharma Ltd. - Key offerings
12.7 Baxter International Inc.
Baxter International Inc. - Overview
Baxter International Inc. - Business segments
Baxter International Inc. - Key news
Baxter International Inc. - Key offerings
Baxter International Inc. - Segment focus
12.8 Biocon Ltd.
Biocon Ltd. - Overview
Biocon Ltd. - Business segments
Biocon Ltd. - Key offerings
Biocon Ltd. - Segment focus
12.9 Celltrion Healthcare Co. Ltd.
Celltrion Healthcare Co. Ltd. - Overview
Celltrion Healthcare Co. Ltd. - Business segments
Celltrion Healthcare Co. Ltd. - Key offerings
Celltrion Healthcare Co. Ltd. - Segment focus
12.10 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product / Service
Eli Lilly and Co. - Key news
Eli Lilly and Co. - Key offerings
12.11 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
12.12 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
12.13 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
12.14 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
12.15 Precision Biologics Inc.
Precision Biologics Inc. - Overview
Precision Biologics Inc. - Product / Service
Precision Biologics Inc. - Key offerings
12.16 Samsung Electronics Co. Ltd.
Samsung Electronics Co. Ltd. - Overview
Samsung Electronics Co. Ltd. - Business segments
Samsung Electronics Co. Ltd. - Key news
Samsung Electronics Co. Ltd. - Key offerings
Samsung Electronics Co. Ltd. - Segment focus
12.17 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Application
Exhibits 6: Executive Summary - Chart on Market Segmentation by Product
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Company Market Positioning
Exhibits 10: Parent Market
Exhibits 11: Data Table on - Parent Market
Exhibits 12: Market characteristics analysis
Exhibits 13: Value Chain Analysis
Exhibits 14: Offerings of companies included in the market definition
Exhibits 15: Market segments
Exhibits 16: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits 17: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits 18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 20: Historic Market Size - Data Table on Global Biologic Therapeutics Market 2018 - 2022 ($ billion)
Exhibits 21: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
Exhibits 22: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
Exhibits 23: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits 24: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits 25: Five forces analysis - Comparison between 2023 and 2028
Exhibits 26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 31: Chart on Market condition - Five forces 2023 and 2028
Exhibits 32: Chart on Application - Market share 2023-2028 (%)
Exhibits 33: Data Table on Application - Market share 2023-2028 (%)
Exhibits 34: Chart on Comparison by Application
Exhibits 35: Data Table on Comparison by Application
Exhibits 36: Chart on Cancer - Market size and forecast 2023-2028 ($ billion)
Exhibits 37: Data Table on Cancer - Market size and forecast 2023-2028 ($ billion)
Exhibits 38: Chart on Cancer - Year-over-year growth 2023-2028 (%)
Exhibits 39: Data Table on Cancer - Year-over-year growth 2023-2028 (%)
Exhibits 40: Chart on Infectious diseases - Market size and forecast 2023-2028 ($ billion)
Exhibits 41: Data Table on Infectious diseases - Market size and forecast 2023-2028 ($ billion)
Exhibits 42: Chart on Infectious diseases - Year-over-year growth 2023-2028 (%)
Exhibits 43: Data Table on Infectious diseases - Year-over-year growth 2023-2028 (%)
Exhibits 44: Chart on Autoimmune diseases - Market size and forecast 2023-2028 ($ billion)
Exhibits 45: Data Table on Autoimmune diseases - Market size and forecast 2023-2028 ($ billion)
Exhibits 46: Chart on Autoimmune diseases - Year-over-year growth 2023-2028 (%)
Exhibits 47: Data Table on Autoimmune diseases - Year-over-year growth 2023-2028 (%)
Exhibits 48: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits 49: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits 50: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 51: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 52: Market opportunity by Application ($ billion)
Exhibits 53: Data Table on Market opportunity by Application ($ billion)
Exhibits 54: Chart on Product - Market share 2023-2028 (%)
Exhibits 55: Data Table on Product - Market share 2023-2028 (%)
Exhibits 56: Chart on Comparison by Product
Exhibits 57: Data Table on Comparison by Product
Exhibits 58: Chart on Antibody therapeutics - Market size and forecast 2023-2028 ($ billion)
Exhibits 59: Data Table on Antibody therapeutics - Market size and forecast 2023-2028 ($ billion)
Exhibits 60: Chart on Antibody therapeutics - Year-over-year growth 2023-2028 (%)
Exhibits 61: Data Table on Antibody therapeutics - Year-over-year growth 2023-2028 (%)
Exhibits 62: Chart on Vaccines - Market size and forecast 2023-2028 ($ billion)
Exhibits 63: Data Table on Vaccines - Market size and forecast 2023-2028 ($ billion)
Exhibits 64: Chart on Vaccines - Year-over-year growth 2023-2028 (%)
Exhibits 65: Data Table on Vaccines - Year-over-year growth 2023-2028 (%)
Exhibits 66: Chart on Cell therapy - Market size and forecast 2023-2028 ($ billion)
Exhibits 67: Data Table on Cell therapy - Market size and forecast 2023-2028 ($ billion)
Exhibits 68: Chart on Cell therapy - Year-over-year growth 2023-2028 (%)
Exhibits 69: Data Table on Cell therapy - Year-over-year growth 2023-2028 (%)
Exhibits 70: Chart on Gene therapy - Market size and forecast 2023-2028 ($ billion)
Exhibits 71: Data Table on Gene therapy - Market size and forecast 2023-2028 ($ billion)
Exhibits 72: Chart on Gene therapy - Year-over-year growth 2023-2028 (%)
Exhibits 73: Data Table on Gene therapy - Year-over-year growth 2023-2028 (%)
Exhibits 74: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits 75: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits 76: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 77: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 78: Market opportunity by Product ($ billion)
Exhibits 79: Data Table on Market opportunity by Product ($ billion)
Exhibits 80: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 81: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 82: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 83: Chart on Geographic comparison
Exhibits 84: Data Table on Geographic comparison
Exhibits 85: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits 86: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits 87: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 88: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 89: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits 90: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits 91: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 92: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 93: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits 94: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits 95: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 96: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 97: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits 98: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits 99: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 100: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 101: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 102: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 103: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 104: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 105: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits 106: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits 107: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 108: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 109: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits 110: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits 111: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 112: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 113: Chart on France - Market size and forecast 2023-2028 ($ billion)
Exhibits 114: Data Table on France - Market size and forecast 2023-2028 ($ billion)
Exhibits 115: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits 116: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits 117: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits 118: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits 119: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 120: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 121: Market opportunity By Geographical Landscape ($ billion)
Exhibits 122: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits 123: Impact of drivers and challenges in 2023 and 2028
Exhibits 124: Overview on criticality of inputs and factors of differentiation
Exhibits 125: Overview on factors of disruption
Exhibits 126: Impact of key risks on business
Exhibits 127: Companies covered
Exhibits 128: Matrix on companies position and classification
Exhibits 129: AbbVie Inc. - Overview
Exhibits 130: AbbVie Inc. - Product / Service
Exhibits 131: AbbVie Inc. - Key news
Exhibits 132: AbbVie Inc. - Key offerings
Exhibits 133: Amgen Inc. - Overview
Exhibits 134: Amgen Inc. - Product / Service
Exhibits 135: Amgen Inc. - Key news
Exhibits 136: Amgen Inc. - Key offerings
Exhibits 137: AstraZeneca Plc - Overview
Exhibits 138: AstraZeneca Plc - Product / Service
Exhibits 139: AstraZeneca Plc - Key news
Exhibits 140: AstraZeneca Plc - Key offerings
Exhibits 141: Aurobindo Pharma Ltd. - Overview
Exhibits 142: Aurobindo Pharma Ltd. - Product / Service
Exhibits 143: Aurobindo Pharma Ltd. - Key offerings
Exhibits 144: Baxter International Inc. - Overview
Exhibits 145: Baxter International Inc. - Business segments
Exhibits 146: Baxter International Inc. - Key news
Exhibits 147: Baxter International Inc. - Key offerings
Exhibits 148: Baxter International Inc. - Segment focus
Exhibits 149: Biocon Ltd. - Overview
Exhibits 150: Biocon Ltd. - Business segments
Exhibits 151: Biocon Ltd. - Key offerings
Exhibits 152: Biocon Ltd. - Segment focus
Exhibits 153: Celltrion Healthcare Co. Ltd. - Overview
Exhibits 154: Celltrion Healthcare Co. Ltd. - Business segments
Exhibits 155: Celltrion Healthcare Co. Ltd. - Key offerings
Exhibits 156: Celltrion Healthcare Co. Ltd. - Segment focus
Exhibits 157: Eli Lilly and Co. - Overview
Exhibits 158: Eli Lilly and Co. - Product / Service
Exhibits 159: Eli Lilly and Co. - Key news
Exhibits 160: Eli Lilly and Co. - Key offerings
Exhibits 161: GlaxoSmithKline Plc - Overview
Exhibits 162: GlaxoSmithKline Plc - Business segments
Exhibits 163: GlaxoSmithKline Plc - Key news
Exhibits 164: GlaxoSmithKline Plc - Key offerings
Exhibits 165: GlaxoSmithKline Plc - Segment focus
Exhibits 166: Merck and Co. Inc. - Overview
Exhibits 167: Merck and Co. Inc. - Business segments
Exhibits 168: Merck and Co. Inc. - Key news
Exhibits 169: Merck and Co. Inc. - Key offerings
Exhibits 170: Merck and Co. Inc. - Segment focus
Exhibits 171: Novartis AG - Overview
Exhibits 172: Novartis AG - Business segments
Exhibits 173: Novartis AG - Key news
Exhibits 174: Novartis AG - Key offerings
Exhibits 175: Novartis AG - Segment focus
Exhibits 176: Pfizer Inc. - Overview
Exhibits 177: Pfizer Inc. - Product / Service
Exhibits 178: Pfizer Inc. - Key news
Exhibits 179: Pfizer Inc. - Key offerings
Exhibits 180: Precision Biologics Inc. - Overview
Exhibits 181: Precision Biologics Inc. - Product / Service
Exhibits 182: Precision Biologics Inc. - Key offerings
Exhibits 183: Samsung Electronics Co. Ltd. - Overview
Exhibits 184: Samsung Electronics Co. Ltd. - Business segments
Exhibits 185: Samsung Electronics Co. Ltd. - Key news
Exhibits 186: Samsung Electronics Co. Ltd. - Key offerings
Exhibits 187: Samsung Electronics Co. Ltd. - Segment focus
Exhibits 188: Sanofi SA - Overview
Exhibits 189: Sanofi SA - Business segments
Exhibits 190: Sanofi SA - Key news
Exhibits 191: Sanofi SA - Key offerings
Exhibits 192: Sanofi SA - Segment focus
Exhibits 193: Inclusions checklist
Exhibits 194: Exclusions checklist
Exhibits 195: Currency conversion rates for US$
Exhibits 196: Research methodology
Exhibits 197: Information sources
Exhibits 198: Data validation
Exhibits 199: Validation techniques employed for market sizing
Exhibits 200: Data synthesis
Exhibits 201: 360 degree market analysis
Exhibits 202: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global biologic therapeutics market: AbbVie Inc., Amgen Inc., Apogenix AG, AstraZeneca Plc, Aurobindo Pharma Ltd., Baxter International Inc., Biocon Ltd., BioMarin Pharmaceutical Inc., Celltrion Healthcare Co. Ltd., Eli Lilly and Co., GangaGen Biotechnologies Pvt Ltd., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Merck and Co. Inc., Novartis AG, Pfizer Inc., Precision Biologics Inc., Samsung Electronics Co. Ltd., Sanofi SA, and Tubulis GmbH.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is strong research and development pipeline."

According to the report, one of the major drivers for this market is the introduction of biosimilars.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • Amgen Inc.
  • Apogenix AG
  • AstraZeneca Plc
  • Aurobindo Pharma Ltd.
  • Baxter International Inc.
  • Biocon Ltd.
  • BioMarin Pharmaceutical Inc.
  • Celltrion Healthcare Co. Ltd.
  • Eli Lilly and Co.
  • GangaGen Biotechnologies Pvt Ltd.
  • GlaxoSmithKline Plc
  • Johnson and Johnson Services Inc.
  • Merck and Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Precision Biologics Inc.
  • Samsung Electronics Co. Ltd.
  • Sanofi SA
  • Tubulis GmbH